WHO ICTRP trial
A Multicenter Study to Evaluate the Immediate and Delayed Effects of…
DRKS00008001 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00008001 |
|---|---|
| Public title | A Multicenter Study to Evaluate the Immediate and Delayed Effects of Individualized Metacognitive Therapy for Psychosis (MCT+) |
| Scientific title | A Multicenter Study to Evaluate the Immediate and Delayed Effects of Individualized Metacognitive Therapy for Psychosis (MCT+) |
| Primary sponsor | Universitätsklinikum Hamburg-EppendorfKlinik und Poliklinik für Psychiatrie und Psychotherapie |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Germany |
| Conditions | F20;Schizophrenia |
| Interventions | Group 1: Individualized Metacognitive Therapy (MCT+) for psychosis is a manualized treatment for therapy in a one-on-one setting (www.uke.de/mkt_plus). It includes the following 11 therapy units: Unit 1: Development of the Therapeutic… |
| Registration date | Jun 5, 2015 |
| Target size | 328 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: